|
AU6316799A
|
|
Use of MCH-II binding and/or MHC-II mimicking molecules for the prevention and/or treatment of inflammatory diseases
|
|
WO9632418A1
|
|
Anti-cd14 antibodies for use in the induction of il-10 secretion
|
|
CZ186897A3
|
|
Use of molecules capable of binding mhc-ii or imitating mhc-ii for preparing a pharmaceutical preparation
|
|
CA2175375A1
|
|
Glucosamine disaccharides, method for their preparation, pharmaceutical composition comprising same, and their use
|
|
HRP940603B1
|
|
Process for the preparation of calcium 2,5-dihydroxy-benzensulfonate
|
|
HRP921282B1
|
|
Process for obtaining bacterial lisate from the sorts of escherichia coli
|
|
HRP921281B1
|
|
Process for the preparation of bacterium lisate
|
|
CH685498A5
|
|
macromolecules bacterial extract, process for its preparation and pharmaceutical composition containing this extract.
|
|
KR0169982B1
|
|
Drug for the treatment of dermatitis
|
|
FI903777A0
|
|
Method for preparing an extracellular exopolymer
|
|
CH674517A5
|
|
Sulphated alkaline dextran and hydro-dextran prepn.
|
|
SI8712281A8
|
|
Process for preparing alkali sulphated dextrane and hydrodextrane which is in essence without sulphate and chloride ion
|
|
US4513007A
|
|
Method for treating heart disease
|
|
US4322405A
|
|
Method for treating rheumatoid arthritis
|
|
DE3019448A1
|
|
IMMUNOBIOTHERAPEUTICAL MEDICINAL PRODUCT AND METHOD FOR THE PRODUCTION THEREOF
|
|
US4252821A
|
|
Method for treating ulcers
|
|
JPS5537498A
|
|
Synthetic magnesium alumino silicate
|
|
CS223968B2
|
|
Method of making the synthetic hydrated magnesium aluminosilicate
|
|
SI7912047A8
|
|
Process for production of synthetic magnesium aluminium silicates.
|
|
YU204779A
|
|
Process for obtaining magnesium aluminium silicates
|
